Roche has announced the launch of cobas 6500, a fully automated urine testing system that consists of two modular analyzers combining urine strip testing and digital urinary microscopy. The system tests for 23 parameters to help diagnose diseases such as urinary tract infection, kidney disease, and diabetes. The cobas 6500 offers the highest throughput on the market, ensures high-quality results and increases laboratory productivity significantly, while reducing manual steps and contamination risks for laboratory staff.
“At the moment, many manual steps are still required for urine analysis. With the cobas 6500 we can offer fully automated urine testing to laboratories, processing more than one thousand urine samples per day, which is significantly more than what can be done today,” said Roland Diggelmann, COO of Roche Diagnostics. “Building on our 50 years of experience in urine analysis, Roche Diagnostics is now entering digital microscopy for urine testing, bringing even higher-quality solutions to the laboratories. This enables laboratories to generate faster and more reliable results for the benefit of people’s health.”
The system will be available in in Europe, the Asia Pacific region, the Middle East, Africa and Latin America. Roche is also planning to submit an application for the approval of the cobas 6500 in the United States.